Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

Middle-aged women, mostly in the 55-64 age range, are top users of the obesity drugs, according to Kela. Nearly half of Finns ...

Wegovy works like its more famous brand-sister product Ozempic, which was originally developed as an anti-diabetic drug. To treat obesity it is used in higher doses. In France, the drugs are ...

Rice University researchers are developing a new implant that could one day manufacture and deliver a diabetes and obesity therapy drug from inside a person's body, reducing the cost of an ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

"This drug should only be used as a second-line treatment, in the event of failure ... The ANSM is also asking doctors treating obesity to prescribe aGLP-1 to patients with an initial body mass ...